5th International Meeting on Biotechnology
Pamplona, September 29th- October 1st 2010
News
October 8, 2010
700 companies with 1,400 participants attend BioSpain 2010
- 21.5% of attending companies came from other countries.
- Attendees held close to 2.200 business meetings.
- ASEBIO and SODENA achieve to make this event an international one.
October 1, 2010
A good policy for the protection of patents, the key to a successful transfer of technology
- Conny Bogentoft, Chief Scientific Officer at Karolinska Development AB, stressed the need to “build bridges between the academic world and the pharmaceutical industry”.
- Participating in the closing ceremony were José María Roig, Regional Minister of Innovation, Business and Labour of the Government of Navarre; José María Fernández Sousa-Faro, President of ASEBIO, and Carmen Vela, the new President of the Spanish Society of Biotechnology (SEBIOT).
September 30, 2010
The number of biotechnology companies has only decreased by 10% despite the crisis
- Larry Fritz, president and CEO of Covella Pharmaceuticals and partner of Westfield Capital Management, has stressed that the current model of venture capital has to be revised.
- In the context of red or medical biotechnology, there are two important fields in which it could play a significant role: personalised medicine and biobetters.
September 29, 2010
ASEBIO requests the alignement of Spain with the European Union's future strategy of Bioeconomy
- The Spanish biotechnology sector has taken important steps during recent years and it would be a shame if it were to retreat due to the current economic crisis.
- The impact of biotechnology in 2010 will represent 1.2% of national GDP according to the Ministry of Science and Innovation, which in 2009 granted this sector 105 million euros in financial aid.
September 15, 2010
Biospain will host 1,500 business meetings in which more than 600 companies will come together
BioSpain 2010 turns things around with regard to prior events focusing on internationalisation as the main pillar of this year’s event .The 2010 macroeconomic impact of biotechnology already amounts to 1.2% of the Spanish GDP.According to the latest report issued by ASEBIO, the size of the Spanish biotechnology sector has almost doubled, regarding the number of companies, from 2005 to 2008.
June 25, 2010
BioSpain becomes more international
This event will take place in Pamplona from September 29th to October 1st and will be honoured to have three lecturers of international prestige, such as Mr. Carlos Cordón-Cardo, Vice-Chair of Pathology & Professor, Columbia University; Mr. Larry Fritz, President & CEO, Covella Pharmaceuticals Inc. and Life Science Venture Partner, Westfield Capital Management Company LP, and Mr. Conny Bogentoft, CEO Karolinska Development AB.
June 4, 2010
Biobide will attend the V International Meeting on Biotechnology 2010 (Biospain)
Biobide S.L. will attend the 5th International Meeting on Biotechnology, Biospain 2010, organised by ASEBIO and SODENA, that is taking place in Pamplona from the 29th of September to the 1st of October 2010. Biobide will be present both in a booth and in partnering meetings.
Madrid / Zurich, March 10, 2010
ASEBIO selects EBD Group’s partneringONE® as the partnering platform for BioSpain 2010
EBD Group, the leading partnering firm for the global biotechnology industry, and ASEBIO, the Spanish Association of Bioenterprises, today announced that EBD Group’s partneringONE® will be the partnering and registration platform for BioSpain, which is widely recognized as the primary exhibition and conference platform for companies and professionals involved in biotechnology in Spain.
January 20, 2010
BioSpain makes Spain a key country for biotechnology industry
Spain has had an early development of biotechnology, and therefore has become one of the countries with most potential for growth within this area.
Contact Biospain 2010
David Fernández
Lucía Cecilia
dfernandez@biospain2010.org
lcecilia@biospain2010.org
lcecilia@asebio.com
+34 912 109 374
